KCI NPWT Sicherheitshinweise, Anwendungsanweisungen Seite 6

Circumferential Dressing Application: Avoid
use of circumferential dressings except in the
presence of anasarca or excessively weeping
extremities, where a circumferential drape
technique may be necessary to establish
and maintain a seal. Consider using multiple
small pieces of V.A.C.® Drape rather than
one continuous piece to minimize the risk
of decreased distal circulation. Extreme care
should be taken not to stretch or pull the drape
when securing it, but let it attach loosely and
stabilize the edges with an elastic wrap, if
necessary. When using circumferential drape
applications, it is crucial to systematically
and recurrently palpate distal pulses and
assess distal circulatory status. If circulatory
compromise is suspected, discontinue therapy,
remove dressing, and contact a treating
physician.
V.A.C.® Therapy Unit Pressure Excursions:
In rare instances, tubing blockages with
the V.A.C.® Therapy Units may result in brief
vacuum excursions to more than 250mmHg
negative pressure. Resolve alarm conditions
immediately. Refer to therapy unit user's guide
or contact your KCI representative for additional
information.
Pressure Points: Monitor location of tubing
connectors, caps and clamps in relation to
patient position to minimize pressure points.
Infected Wounds with KCI® NPWT Gauze
Dressing: Not intended as a treatment for
clinical infection. If signs of clinical infection
are present, consult a physician. Kerlix™ AMD™
Dressings can be used in conjunction with the
prescribed therapy.
6
CONSIDERATIONS FOR TRANSITIONING
NEGATIVE PRESSURE WOUND THERAPY
INTO HOME CARE
WARNING: Patients with an increased
risk of bleeding complications should
be treated and monitored in a care
setting deemed appropriate by the
treating physician.
In addition to the contraindications, warnings
and precautions for use of NPWT, consider the
following before prescribing NPWT for use in
the home care setting.
•
The Patient's Situation:
•
Clinical condition (adequate hemostasis,
and a low risk of active and / or large
amounts of bleeding at the wound site)
•
Home environment (patient or family
member / caregiver able to read and
understand safety labeling, able to respond
to alarms, able to follow instructions for
use)
• The Patient's Wound:
•
Must be assessed for exposed vessels,
anastomotic sites, organs, and nerves.
Adequate protection must be present
without the need for a protective, non-
adherent layer placed between the gauze
dressing and the exposed structure for
the sole purpose of protection of these
structures (refer to Protect Vessels and
Organs in the Warnings section).
•
The V.A.C.® Therapy Unit Canister Size:
•
The 1000 mL canister is NOT intended for
use in the home.
•
Labeling:
•
The prescribing physician and health care
clinician should be familiar with the NPWT
labeling materials that accompany the
therapy unit and dressing cartons into the
home.
•
An information folder is provided with the
therapy unit. The prescribing physician and
/ or healthcare clinician should carefully
review these materials with the patient and
patient's caregiver.
•
KCI o ers in-service and training programs
for use of NPWT. Contact your local KCI
representative.